As of Mar 27
| -0.29 / -4.62%|
The 2 analysts offering 12-month price forecasts for Columbia Laboratories Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +91.99% increase from the last price of 5.99.
The current consensus among 2 polled investment analysts is to Buy stock in Columbia Laboratories Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.